Thus, CRY deficiency and PER overexpression appear to act similarly in inhibiting tumor growth, suggesting that disruption of circadian genes during aging involves a complex interplay between their roles in the circadian clock and other cellular processes and pathways [50]. The gene discussed is CLOCK; the disease is neoplasm.